BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32636303)

  • 1. Interleukin-6-mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors.
    Hegde M; Guruprasad KP; Ramachandra L; Satyamoorthy K; Joshi MB
    J Biol Chem; 2020 Aug; 295(34):12086-12098. PubMed ID: 32636303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 determines protein stabilization of DNA methyltransferases and alters DNA promoter methylation of genes associated with insulin signaling and angiogenesis.
    Balakrishnan A; Guruprasad KP; Satyamoorthy K; Joshi MB
    Lab Invest; 2018 Sep; 98(9):1143-1158. PubMed ID: 29955086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
    Ray A; Alalem M; Ray BK
    J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response.
    Zafarnia S; Bzyl-Ibach J; Spivak I; Li Y; Koletnik S; Doleschel D; Rix A; Pochon S; Tardy I; Koyadan S; van Zandvoort M; Palmowski M; Kiessling F; Lederle W
    Neoplasia; 2017 Nov; 19(11):896-907. PubMed ID: 28938160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways.
    Zhou Z; Mao W; Li Y; Qi C; He Y
    Anat Rec (Hoboken); 2019 Dec; 302(12):2186-2192. PubMed ID: 31266091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells.
    Park Y; Kim J
    BMB Rep; 2019 Mar; 52(3):214-219. PubMed ID: 30670152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
    Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
    Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
    Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
    J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
    Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
    J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
    Bhattacharya R; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo monitoring of angiogenesis inhibition via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer model using bioluminescent imaging.
    Zhao D; Tu Y; Wan L; Bu L; Huang T; Sun X; Wang K; Shen B
    PLoS One; 2013; 8(8):e71472. PubMed ID: 23951172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.
    Yang H; Lee S; Lee S; Kim K; Yang Y; Kim JH; Adams RH; Wells JM; Morrison SJ; Koh GY; Kim I
    J Clin Invest; 2013 Jan; 123(1):418-31. PubMed ID: 23241958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis.
    Ji W; Li Y; He Y; Yin M; Zhou HJ; Boggon TJ; Zhang H; Min W
    Cancer Res; 2015 Sep; 75(17):3492-504. PubMed ID: 26139244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
    Wang J; Yang L; Liang F; Chen Y; Yang G
    J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wu-Tou Decoction Inhibits Angiogenesis in Experimental Arthritis by Targeting VEGFR2 Signaling Pathway.
    He L; Liu C; Sun C; Wang J; Zhi K; Sun D; Wang H; Wang Q; Lin N
    Rejuvenation Res; 2018 Oct; 21(5):442-455. PubMed ID: 29385909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
    Lu Y; Xu Q; Zuo Y; Liu L; Liu S; Chen L; Wang K; Lei Y; Zhao X; Li Y
    BMC Cancer; 2017 Dec; 17(1):875. PubMed ID: 29262812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.